AYTU BIOPHARMA, INC Current Assets
AYTU BIOPHARMA, INC (AYTU) had Current Assets of $61.76 million as of 2026-06-30, per its 10-K filed 2026-09-22.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-09-22
- 2026-06-30: Assets, Current $61.76M.
- 2026-03-31: Assets, Current $67.33M.
- 2025-12-31: Assets, Current $76.24M.
- 2025-09-30: Assets, Current $81.11M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $61.76M 10-K · filed 2026-09-22 | |
| 2026-03-31 | $67.33M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $76.24M 10-Q · filed 2026-02-03 | |
| 2025-09-30 | $81.11M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $79.18M 10-K · filed 2026-09-22 | |
| 2025-03-31 | $72.51M 10-Q · filed 2025-05-14 | |
| 2024-06-30 | $61.89M 10-K · filed 2025-09-23 | |
| 2024-03-31 | $71.13M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $71.37M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $70.60M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $72.83M 10-Q · filed 2024-05-15 | |
| 2023-03-31 | $78.47M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $70.61M 10-Q · filed 2023-02-21 | |
| 2022-09-30 | $74.42M 10-Q/A · filed 2023-02-21 | |
| 2022-06-30 | $59.93M 10-K · filed 2023-10-12 | |
| 2022-03-31 | $77.95M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $87.54M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $89.04M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $105.23M 10-K · filed 2022-09-27 | |
| 2021-03-31 | $100.01M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $92.54M 10-Q · filed 2021-02-11 | |
| 2020-09-30 | $65.45M 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $75.42M 10-K · filed 2021-09-28 | $74.97M 10-K · filed 2020-10-06 |
| 2020-03-31 | $83.25M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $18.34M 10-Q · filed 2020-02-14 | |
| 2019-09-30 | $11.98M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $15.43M 10-K · filed 2020-10-06 | |
| 2019-03-31 | $18.46M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $21.98M 10-Q · filed 2019-05-14 | |
| 2018-09-30 | $6.87M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $9.47M 10-K · filed 2019-09-26 | |
| 2018-03-31 | $14.59M 10-Q · filed 2018-05-14 | |
| 2017-12-31 | $7.74M 10-Q · filed 2018-02-08 | |
| 2017-09-30 | $9.74M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $3.03M 10-K · filed 2018-09-06 | |
| 2017-03-31 | $4.44M 10-Q · filed 2017-05-11 | |
| 2016-12-31 | $8.16M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $6.36M 10-Q · filed 2016-11-07 | |
| 2016-06-30 | $10.12M 10-K · filed 2017-08-31 | |
| 2016-03-31 | $10.44M 10-Q · filed 2016-05-11 | |
| 2015-12-31 | $12.76M 10-Q · filed 2016-02-11 | |
| 2015-09-30 | $11.31M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $8.04M 10-K · filed 2016-09-01 | $8.08M 10-K · filed 2015-09-28 |
| 2015-03-31 | $1.65M 10-Q · filed 2015-05-19 | |
| 2015-02-28 | $7.13K 10-Q · filed 2015-04-15 | |
| 2014-11-30 | $9.32K 10-Q · filed 2015-01-12 | |
| 2014-08-31 | $2.49K 10-Q · filed 2015-04-15 | |
| 2014-06-30 | $3.30M 10-K · filed 2015-09-28 | $3.31M 10-Q · filed 2015-05-19 |
| 2014-05-31 | $9.28K 10-Q · filed 2014-07-10 | |
| 2014-02-28 | $213.00 10-Q · filed 2014-04-11 | |
| 2013-11-30 | $552.00 10-Q · filed 2014-01-10 | |
| 2013-08-31 | $1.86K 10-K · filed 2014-11-26 | |
| 2013-05-31 | $728.00 10-Q · filed 2013-06-28 | |
| 2013-02-28 | $3.19K 10-Q · filed 2013-04-15 | |
| 2012-11-30 | $701.00 10-Q · filed 2013-01-14 | |
| 2012-08-31 | $186.00 10-K · filed 2014-11-26 | |
| 2012-05-31 | $202.00 10-Q · filed 2012-06-26 | |
| 2012-02-29 | $1.00K 10-Q · filed 2012-04-12 | |
| 2011-11-30 | $1.87K 10-Q · filed 2011-12-23 | |
| 2011-08-31 | $4.23K 10-K · filed 2012-11-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |